Diabetes Dialogue: SURMOUNT-3 and -4 Inform Use of Tirzepati

In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US Food and Drug Administration for chronic weight management.

Related Keywords

Eli Lilly , Natalie Bellini , Diana Isaacs , Provention Bio , Diabetes Technology At University Hospitals , Training In Diabetes Technology , European Association For The Study Of Diabetes , Drug Administration , Novo Nordisk , Metabolic Care Center , Medtronic , European Association , Annual Meeting , Confidence Interval , Diabetes Dialogue , Real World Perspectives , Diabetes Technology , Endocrine Disorders , Cleveland Clinic , University Hospitals Diabetes , Abbott Diabetes Care , Tirzepatide , Mounjaro , Surmount 4 , Surmount 3 And 4 , Surmount 3 , Ttirzepatide Mounjaro ,